Exact Sciences Corporation kicked off the trading day on 09/10/19 with a price increase of 0.25%, equivalent to $0.27 relative change for the day. Taking a more long-term approach, EXAS had a 52-week range of $53.06 to $123.99. At the time of this article’s publishing, this stock is trading at $109.01 after starting the trading session at $109.56. At the time of writing, this stock’s 50-day Moving Average stands at $117.28, while the 200-day Moving Average of this stock is currently $95.87.
Currently, this company’s share volume is sitting at $3,209,172, but has maintained average daily volume of $1.49M. This stock has generated an average Year to Date volume of $1.72 million, alongside an average 20-day volume of $1.28 million. This publicly-traded company’s shares outstanding now amounts to $131.23 million, simultaneously with a float of $127.76 million. The organization now has a market capitalization sitting at $14.31 billion.
Exact Sciences Corporation(EXAS) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. Exact Sciences Corporation’s current insider ownership accounts for 1.10%, in contrast to 90.90% institutional ownership. According to the most recent latest insider trade that took place on Jul 31 this organization’s Director exercised an option 42,607 at the rate of 5.31, making the entire transaction hit 226,421 in total value, affecting insider ownership by 55,065. Preceding that transaction, on Jul 31 Company’s Director exercised an option 2,500 at a price of 26.98, making the whole transaction’s value amount to 67,450. This particular insider is now the holder of 13,913 in total.
If we take a glance at the Ownership summary of Exact Sciences Corporation’s stock, Institutional holders make up 90.90% of its total stock ownership. All together, they are the legal holders of 131.23M shares. If we focus on the top 3 stockholders for this publicly-traded organization, The Vanguard Group, Inc. owns 11,400,249 shares, with T. Rowe Price Associates, Inc. (Investment Management) in 2nd place owning 7,184,601 shares and BlackRock Fund Advisors in third place with total ownership of 5,285,766 shares.
Exact Sciences Corporation (EXAS) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported -$0.3 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at -$0.56) by $0.26.
This company achieved a net margin of -35.43 while generating a return on equity of -29.97. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
Exact Sciences Corporation’s EPS increase for this current 12-month fiscal period is 30.70%, and is forecasted to reach 51.50% in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 20.00% through the next 5 years, which can be compared against the -15.80% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
Now turning our attention to the current performance indicators for Exact Sciences Corporation, this organization’s Quick Ratio in the last reported quarter now stands at 2.70. The company has managed to achieve an average true range (ATR) of 4.76. Alongside those, its Beta score is 1.46.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 22.95 for this organization. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 18.38, whereas its price to cash per share for the last quarter landed at 9.45.
In the same vein, EXAS’s Diluted EPS (Earnings per Share) trailing twelve months was posted at -1.76, a figure that is expected to reach -0.39 in the next reported quarter, and analysts expect it will be 51.50% at the market close of one year from today’s date.